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Abstract 
Purpose: To evaluate the possible toxicity of a blend of three spices, namely, garlic (Allium sativum), 
ginger (Zingiber officinale) and cayenne pepper (Capsicum frutescens) in Wistar rats  
Methods: For acute toxicity test, five females and five male rats were given a single oral dose of 5000 
mg/kg body weight of aqueous extract of the spice blend and observed for 14 days. Sub-acute toxicity 
was assessed by giving male and female rats 200, 500 and 1000 mg/kg body weight oral doses of the 
spice blend on a daily basis for 28 days, while controls were administered distilled water. At the end of 
the experiment, blood and tissues were collected for haematological, biochemical and histological 
evaluations.  
Results: The haematological indices of treated rats did not reveal any significant (p > 0.05) differences 
from those of control except for elevation in lymphocyte count which was significant (p < 0.05) in the 500 
and 1000 mg/kg treated male groups. Activities of serum alkaline phosphatise (ALP), gamma glutamyl 
transpeptidase (GGT), alanine transaminase (ALT), aspartate transaminase (AST) and creatine kinase 
(CK), as well as concentration of total cholesterol and triglycerides were significantly reduced (p < 0.05) 
following treatment with the extract of the spice blend. Histological examinations of the liver did not 
reveal any pathological changes attributable to treatment with the spice blend extract.  
Conclusions: These findings indicate that oral consumption of a spice blend of garlic, ginger and 
cayenne pepper in humans may be safe. 
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Spices are single or blends of aromatic and 
pungent herbal substances used as condiments 
which generally give characteristic taste, flavour, 
colour and aroma to foods. For ages, spices 
have been used as seasonings in foods as well 
as for medicinal purposes. About 80 % of the 
populations in Africa and Asia still rely on plant 
extracts, including spices with dietary 
importance, to treat several health problems 
such as cancer, diabetes, obesity, hepatic, renal 
and cardiovascular diseases [1].  
Herbal infusions have been recognized as 
important sources of antioxidants which can be 
consumed on a daily basis as decoctions.  
Generally, spices are good sources of 
antioxidants [2] because of which many spices 
are now used therapeutically for the maintenance 
of good health. For example, while some spices 
are used as carminatives, and for the 
improvement of circulatory, hypolipidemic, 
stomachic problems, others are used as 
stimulants, antispasmodics or for protection 
against gastrointestinal disturbances. 
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Allium sativum L. (garlic), Zingiber officinale 
Rosc. (ginger) and Capsicum fructescens L. 
(cayenne pepper) are common spices used in 
cuisines all over the world. These three spices 
are available worldwide and are used, often as 
blends with other spices and medicinal plants for 
culinary and folkloric medicinal purposes.  
 
Garlic (Alliacae) is effective in preventing heart 
disease and in boosting immune systems in 
humans; and the anti-microbial, anti-
hypertensive, anti-cancer, immunomodulatory 
and hypolipidemic properties of garlic have been 
reported [3]. Ginger is an herbaceous perennial 
plant of the family Zingiberacae. Its aromatic and 
pungent rhizome has been used for centuries 
throughout the world, especially in Chinese, 
Japanese and Indian cuisines as spice and 
medicine. Ginger is well known for its anti-
inflammatory, anti-cancer, anti-emetic and 
stomach protective properties [4,5]. Cayenne 
pepper belongs to the Solanaecae family and is 
a source of important vitamins such as A, C and 
E. Its constituents include polyphenols, 
capsaicinoids and carotenoids. Traditionally, 
cayenne is used as remedy for rheumatic and 
arthritic pains, in the treatment of hyperglycaemia 
and hypercholesterolemia [6,7]. The species has 
also been reported to enhance lymphocyte 
proliferation and serum immunoglobulin levels as 
well as to correct erectile dysfunction.  
 
Although most of the spices used for dietary, 
culinary and medicinal purposes are relatively 
safe and non-toxic to consumers, however, 
investigation of medicinal plants and their ability 
to produce toxic and adverse consequences is of 
current research focus [8,9]. It is therefore, 
necessary to evaluate and scientifically examine 
the possible acute and sub-acute toxicities of 
spices especially those that are consumed in 
large quantities. 
 
The beneficial health effects and safety of each 
of garlic, ginger and cayenne pepper have been 
extensively studied [4,6,10,11,15,16]. However, 
despite long record of usage for various 
purposes, there is a dearth of information on the 
toxicity/safety of their associated use as a blend 
in the literature. Therefore, this study was 
undertaken to determine the possible oral toxicity 




Collection and preparation of the spice blend 
 
The fresh spices were purchased from the 
vegetable market in Alice, Eastern Cape, South 
Africa. The individual spices were cleaned, 
sliced, dried at 60 °C for 72 h and then 
pulverised. Equal amount of each spice was 
weighed (1:1:1, w/w/w) and mixed thoroughly to 
give the spice blend. The aqueous extract of the 
spice blend was obtained by extracting 50 g of 
the spice in 1000 mL of distilled water at 100 °C 
for 60 min. The filtrate was freeze-dried and 
stored 4 °C. 
 
Experimental animals  
 
Adult male and female (nulliparous) Wistar rats 
(175 - 195 g) were obtained from the Animal 
Unit, of the University of Fort Hare, South Africa. 
The rats were divided into groups of control and 
spice treated, with 5 male and 5 female rats in 
each group. The rats were kept under standard 
laboratory conditions (12 h light and dark cycle; 
24 ± 2 °C). The animals were fed with standard 
rat pellet diet and water ad libitum. The study 
was carried out and the animals were handled 
according to the guidelines of the National 
Research Council Guide for the Care and Use of 
Laboratory Animals [12]. The study was 
approved by the University of Fort Hare Animal 
Use Research Ethics Committee (AREC: 
AFO011).  approved by the Animal Use Ethics 
Committee, University of Fort Hare, Alice, South 
Africa.  
 
Acute toxicity  
 
Acute toxicity of the spice mixture was evaluated 
following the Organization for Economic 
Cooperation and Development guidelines 420. 
Limit dose of 5000 mg/kg body weight was used 
[13] [18,19]. The rats were administered a single 
oral dose (5000 mg/kg body weight) of the spice 
extract and observed for body weight, signs of 
toxicity and mortality during 14 days. The rats 
were fasted for 16 - 18 h and then sacrificed. The 
liver, kidney, heart, lung and pancreas were 
removed, weighed and observed for any 
histopathological defects. 
 
Sub-acute toxicity  
 
Sub-acute toxicity was conducted according to 
the OECD [14,20,21] guidelines. The animals 
were distributed into four groups made up of 10 
rats (5 males and 5 females) each. Three of the 
groups [male: nulliparous female=1:1; (rats of 
opposite sex were placed in different cages)] 
were given doses (200, 500 and 1000 mg/kg 
body weight) of the spice extract by oral gavage. 
The 4th group (control) received distilled water for 
28 days. The animals were weighed on the first 
day of the experiment and then every week for 
28 days.  At the end of the experiment (29th day) 
blood samples were collected through the 
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common carotid artery of fasted animals under 
anaesthesia (3 % pentobarbital sodium; dose: 50 
mg/kg). Parts of the liver were fixed in 10 % 
formalin for histopathological examination.  
 
Determination of haematological and 
biochemical parameters 
 
An automated haematology analyzer (Beckman 
Coulter, Inc, USA) was used to determine blood 
parameters; while a chemistry analyser (Abaxis 
Inc, Union City, CA, USA.) was used for the 
biochemical indices. Haematological parameters 
evaluated include haemoglobin, red blood cell 
(RBC), white blood cell (WBC) and platelet (PLT) 
counts. Other parameters include haematocrit, 
mean corpuscular volume (MCV), mean 
corpuscular haemoglobin concentration (MCHC) 
and white blood cell differential count.  
 
Biochemical indices determined were serum 
electrolytes, total protein, total cholesterol and 
triglycerides. Also estimated were serum marker 
enzymes for liver, kidney and heart functions 
including alkaline phosphatase (ALP), gamma 
glutamyl transpeptidase (GGT), creatine kinase 
(CK), alanine and aspartate amino 




Thin sections of the liver already fixed in 10 % 
formalin were prepared, embedded in paraffin 
wax, stained with hematoxylin/eosin and 





Data are expressed as mean ± standard 
deviation (SD, n = 5). A single-factor parametric 
one-way analysis of variance, followed by 
Duncan’s Multiple Range Test was used to 
determine significant differences among 
treatment means. Data were considered 
significant at p < 0.05. All statistical analyses 
were performed using the Minitab Student 
Version 12 for Windows Software (Minitab, Inc. 






The limit test results revealed that a single oral 
dose of aqueous extract of the spice mixture 
(garlic, ginger and cayenne pepper), did not 
cause mortality of the rats within 72 h and during 
the 14 d observatory period. No obvious adverse 
clinical or behavioural changes attributable to 
toxicity of the extract were observed. 
Furthermore, there was no anomaly in food and 
water intake (data not shown) of the rats. In 
addition, body weight gain was not affected by 
the spice extract neither was there any evident 




Effect of the spice blend extract on body and 
relative organ weights of rats revealed that doses 
of 200, 500 and 1000 mg/kg body weight for 28 
days produced no mortality in either sex.  There 
were no clinical signs of diarrhoea, scabbing, 
loss of appetite, pilo-erection, lacrimation, 
convulsion, salivation, voicification and 
prostration during the period of exposure to the 
spice extract. In addition, body and organ 
weights were not significantly different among 
treated and control animals (Figure 1). 
 
Effect of sub-acute administration of spice 
blend extract on blood and biochemical 
indices  
 
Administration of extract of the spice blend for 28 
d revealed no significant change in the blood 
parameters of treated rats except for an increase 
in lymphocyte count, as well as a decrease in the 
monocyte count of rats given the 500 and 1000 
mg/kg doses respectively (Figure 2).  Table 1 
shows the effect of the spice blend extract on 
lipid and electrolyte profiles of the animals. 
 
Effect of the spice extracts on hepatic, renal and 
cardiac enzymes are shown in Figure 3. 
Significant (p < 0.05) dose-dependent reduction 
in the activities of ALP, ALT and CK was 
observed in all the rats given the spice blend 
extract. None statistically significant decrease in 
the activities of aspartate amino transaminase 
and gamma glutamyl transpeptidase were also 
recorded for the treated animals. 
 
Effect of sub-acute administration of aqueous 
extract of spice blend on histology of rat 
organs 
 
Histopathological examination of the liver did not 
reveal any spice blend induced changes. Figure 
4 reveals that no lesions, necrosis or pathological 
changes were present in the liver of the spice 
blend treated rats. No lesions, necrosis or 
pathological changes of the various organs were 
observed in all the treated groups.  
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Figure 1: Body weights of A- male, B- female  rats and relative organ to body weights C, D following 28-days 
sub-acute oral administration with different doses of spice blend. Values are means ± SD (n=5). Spice blend 
administered at 200, 500, 1000 mg/kg body weight doses respectively 
 
Serum total cholesterol, triglycerides, total 
protein, creatinine and urea concentrations were 
significantly (p < 0.05) reduced in the treated rats 
compared to control. In addition, the magnesium 
and chloride ion concentrations of the treated 
rats (both male and females), were also 





In acute toxicity study, rats administered extract 
of the spice blend at the limit dose of 5000 mg/kg 
did not show any signs of toxicity such as 
excessive loss in body weight, increased organ 
weight or general physical and physiological 
misbehaviour. This is an indication that the no-
observed-adverse-effect-level (NOAEL) of the 
extract is greater than the limit dose and that the 
spice blend at a dose of 5000 mg/kg weight had 
no toxic effect on rats.  
 
Although spices and spice blends have been 
used traditionally for their culinary and medicinal 
properties, there are little or no studies reporting 
their safety on repeated uses. In this study, we 
report that sub-chronic administration of the 
spice blend extract at 200, 500 and 1000 
mg/kg/day for 28 days, was not toxic. 
 
Body and organ weights of experimental animals 
are important tools used in toxicity evaluation of 
drugs and plant extracts. According to Teo et al 
[15], loss in body and relative organ weights are 
indicative of toxicity. 
 
In this study, we observed no significant 
differences in body weights of rats following 
repeated oral administration of the spice for 28 
days at different doses. All the experimental 
animals exhibited increase in body weight 
commensurate with feed intake and no statistical 
differences in the organs investigated. These 
observations (increase in body weight and lack of 
any effect on organ weight and mortality) could 
be attributed to the nutrient content of the feed, 
as well as antioxidant constituents such as 
flavonoids, phenols and alkaloids present in the 
spice blend [16]. Since no reduction in body 
weight and organs of the treated rats was 
observed at all the doses, this suggests that the 
spice blend is not toxic. 
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Figure 2: Haematological indices of male and female rats following 28-days sub-acute oral administration at 
different doses of spice mixture. Values are means ± SD (n=5),  RBC(x106/µl)-red blood cell count, Hb-
haemoglobin (g/dl), Hc-haematocrit (%), MCV-mean corpurscular volume (fl), MCHC-mean corpurscular 
haemoglobin concentration (g/dl), Platelet (x105/µl),WBC (x106/µl)-white blood cell count, Neutro (%)-neutrohpils, 
Lympho (%)-lymphocytes, Eosino (%)-eosinophils 
 
Another important index of toxicity is the 
haematopoietic system, which has been reported 
to be highly indicative especially when data from 
animal studies are extrapolated for humans [17]. 
Treatment with extract of the spice blend did not 
produce any deleterious effect on haematological 
parameters, suggesting that the haematological 
system was not affected by the spice extract. 
The concentration dependent increase in 
lymphocytes is an indication that the spice 
extract contains bioactive compounds that can 
boost the immune system, while reduced 
monocytes suggest the absence of infection. 
These are good indicators of the absence of 
inflammation and toxicity; and support the 
reported lymphocyte proliferation and 
immunomodulatory properties of the spices 
[5,18,19,25,26]. Moreover, all the changes 
observed were within normal ranges. 
The major site for metabolism of cholesterol, 
sugar, nutrients and drugs is the liver. 
Significantly lower values of cholesterol, 
triglycerides and glucose in the treated rats 
corroborates earlier report on the hypolipidaemic 
property of aqueous extract of the mixture of 
garlic, ginger and pepper in rats [20]. This implies 
that the mixture possess both hypolipidaemic 
and hypoglycaemic properties.  
 
Evaluation of liver and kidney functions are very 
important in toxicity assessment of plant extracts 
because both organs are necessary for the 
survival and wellbeing of an organism. 
Electrolyte functions are often considered when 
assessing kidney function. Increase or decrease 
in electrolytes such as sodium, potassium, 
chloride and magnesium ions could indicate 
renal injury [21]. Kidney function assessed using  
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Table 1: Effects of aqueous extract of spice mixture (garlic, ginger and cayenne pepper) on blood biochemistry of 
Wistar rats following a 28-day sub-acute treatment 
 
Parameter  Control (mg/kg) 200 (mg/kg) 500 (mg/kg) 1000 (mg/kg) 
Male rats     
Cholesterol (mmol/l) 2.63±0.11a 1.04±0.22b 1.14±0.08b 1.06±0.05b 
Triglycerides (mmol/l) 0.53±0.01a 0.38±0.05b 0.50±0.16a 0.36±0.03b 
Glucose (mmol/l) 3.74±1.23a 3.26±0.76a 3.72±1.44a 3.28±0.92a 
Total protein (mg/dl) 63.00±1.41a 63.40±2.00a 57.40±4.09b 62.00±1.23a 
Albumin (mg/dl) 34.20±1.07a 35.00±0.00a 33.80±0.84ab 35.00±1.00a 
Creatinine (µmol/l) 23.60±3.13a 22.20±3.29b 22.00±6.78b 22.40±1.09b 
Urea (mmol/l) 6.40±2.24a 6.80±0.41a 5.50±1.34b 4.26±0.84bc 
Sodium (mmol/l) 139.20±2.17a 141.00±1.87a 141.40±2.19a 140.20±0.84a 
Chloride (mmol/l) 103.80±1.30a 103.20±1.79a 101.40±0.89b 104.00±0.00ac 
Potassium (mmol/l) 6.00±0.58a 5.76±0.27b 6.98±1.22a 5.54±0.25b 
Magnesium (mmol/l) 0.79±0.53a 1.10±0.04b 1.19±0.11b 1.15±0.07b 
Calcium (mmol/l) 2.40±0.17a 2.45±0.06a 2.55±0.08a 2.45±0.05a 
Female rats     
Cholesterol (mmol/l) 2.74±0.05a 2.77±0.33a 2.40±0.18b 2.40±0.54b 
Triglycerides (mmol/l) 0.52±0.00a 0.55±0.13a 0.53±0.01a 0.51±0.23a 
Glucose (mmol/l) 3.74±1.23a 3.26±0.76ab 3.72±1.44a 3.28±0.92ab 
Total protein (mg/dl) 64.40±0.55a 62.40±1.71b 61.80±2.05b 61.40±2.07b 
Albumin (mg/dl) 33.60±0.55a 32.40±0.78a 31.20±1.09ab 30.60±0.55ab 
Creatinine (µmol/l) 20.40±3.72a 20.78±1.98a 20.35±1.09a 20.20±2.78a 
Urea (mmol/l) 6.44±0.54a 6.40±0.51a 5.49±0.33b 5.86±0.56b 
Sodium (mmol/l) 136.20±1.09a 137.40±0.81ab 138.60±0.55ab 137.00±0.71ab 
Chloride (mmol/l) 102.60±0.55a 103.40±1.67ab 103.60±1.21ab 103.40±1.14ab 
Potassium (mmol/l) 6.24±0.43a 5.70±1.21b 5.36±0.08b 5.04±0.71b 
Magnesium (mmol/l) 1.13±0.08a 1.26±0.54a 1.08±0.07a 1.13±0.11a 
Calcium (mmol/l) 2.52±0.19a 2.59±0.12a 2.56±0.06a 2.62±0.01a 
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Figure 3: Serum marker enzymes of A-male and B-female rats following 28-days sub-acute oral administration 
with different doses of spice mixture. Values are means ± SD (n=5/sex/dose), Spice blend administered at 200, 
500, 1000 mg/kg body weight  doses, respectively 
 
serum creatinine, urea and electrolyte 
concentrations in this study indicates that these 
parameters were not significantly affected by 
treatment with the spice extract and therefore, do 
not alter kidney function at all the doses 
investigated. 
 
Measurement of serum enzymes are often used 
as indicators and type of damage to any organ or 
tissue. Several enzymes found in the serum are 
present because of leakage from damaged 
tissues due to alteration in membrane 
permeability. The transaminases (ALT and AST), 
ALP, GGT and CK are well known predictors of 
toxicity [22]. The modest dose-dependent 
reduction of these marker enzymes observed in 
this study, suggests inhibition or inactivation of 
enzyme  activities  in  situ  by  the bioactive com- 
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Figure 4: Micrographs showing liver architecture of A,B- control; C,D-1000 mg/kg; E,F-500 mg/kg; and G,H-200 
mg/kg body weight of male and female rats administered the spice blend extract 
 
pounds present in the spices. Sulphur containing 
amino acids such as allicin present in garlic have 
been reported to decrease the activities of serum 
enzymes like ALP, AST and ALT [3,11]. In this 
study, we observed no negative indices of 
hepatic, nephrotic or cardiac functions, 
suggesting that the sub-chronic administration of 
the spice blend did not compromise these 
organs. 
 
Histopathological assessment of tissues and 
organs are often used to provide supportive 
evidence for haematological and biochemical 
observations in toxicity studies. In this study, the 
absence of any morphological alterations, 
abnormalities, specific changes or lesions in the 
liver architecture of the treated rats compared 
with the control, supported the biochemical 
results that repeated intake of the spice blend 
orally at the given doses had no toxic effect on 
the liver. Thus, these results indicated the 




To the best of our knowledge, this is the first 
report on the acute and sub-acute oral toxicity 
profile of a spice blend of garlic, ginger and 
cayenne pepper. The findings could be useful in 
future clinical studies of the therapeutic 
properties of this spice blend. The results 
indicated that oral consumption of aqueous 
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